Entera Bio Ltd reports results for the quarter ended in September - Earnings Summary

Entera Bio

10/11/2022 23:19

* Entera Bio Ltd  ENTX.OQ  reported a quarterly adjusted
loss
of 11 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 13 cents per share.
    * Revenue fell 94.3% to $8.00 thousand from a year ago;
analysts
expected $70.00 thousand. 
    * Entera Bio Ltd's reported EPS for the quarter was a loss
of 11
cents​.
    * The mean earnings estimate of analysts had risen by
about 22.9%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Entera Bio Ltd shares had fallen by 41.3% this quarter and
lost 78.3% so far this year.
    * The company reported a quarterly loss of $3.07 million.
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$7.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 11:18 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.13          -0.11          Beat
 Jun. 30 2022      -0.16          -0.11          Beat
 Mar. 31 2022      -0.18          -0.13          Beat
 Dec. 31 2021      -0.23          -0.21          Beat